Veeva Systems Inc. $VEEV Shares Sold by D.A. Davidson & CO.

D.A. Davidson & CO. reduced its stake in shares of Veeva Systems Inc. (NYSE:VEEV) by 74.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,245 shares of the technology company’s stock after selling 6,497 shares during the quarter. D.A. Davidson & CO.’s holdings in Veeva Systems were worth $394,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of VEEV. SHP Wealth Management acquired a new position in shares of Veeva Systems in the 4th quarter valued at $26,000. Newbridge Financial Services Group Inc. grew its position in Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 100 shares during the period. Activest Wealth Management increased its holdings in Veeva Systems by 3,175.0% in the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after buying an additional 127 shares in the last quarter. MV Capital Management Inc. purchased a new position in Veeva Systems in the fourth quarter valued at $30,000. Finally, Reflection Asset Management acquired a new position in shares of Veeva Systems in the fourth quarter worth about $32,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insider Activity

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $155.64, for a total transaction of $116,730.00. Following the sale, the director directly owned 3,253 shares of the company’s stock, valued at $506,296.92. This trade represents a 18.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

VEEV has been the topic of several research analyst reports. Robert W. Baird raised their price objective on Veeva Systems from $250.00 to $260.00 and gave the company an “outperform” rating in a report on Thursday, June 4th. Zacks Research downgraded shares of Veeva Systems from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 14th. Barclays cut their target price on Veeva Systems from $250.00 to $235.00 and set an “overweight” rating for the company in a research note on Thursday, June 4th. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Saturday, July 18th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $270.00 price objective on shares of Veeva Systems in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $247.08.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Guggenheim upgraded Veeva Systems to strong-buy and later set a $232 price target, implying meaningful upside from current levels. Tickerreport.com
• Positive Sentiment: Investor interest is being supported by articles highlighting Veeva as a cash-heavy stock with financial stability, which may appeal to defensive growth investors. Yahoo Finance
• Positive Sentiment: Recent commentary points to steady execution and attractive P/E multiples, reinforcing the view that Veeva’s fundamentals remain solid ahead of its next earnings report. Seeking Alpha
• Neutral Sentiment: Several recent articles focus on what to expect from Veeva’s next earnings release and broader analyst sentiment, suggesting the stock may remain sensitive to upcoming guidance and results. MSN
• Negative Sentiment: The stock had recently declined more than the broader market, reminding investors that near-term volatility remains a risk despite the positive analyst coverage. Yahoo Finance

Veeva Systems Stock Up 3.6%

Shares of VEEV opened at $186.06 on Friday. The company has a 50-day simple moving average of $174.59 and a 200-day simple moving average of $181.60. The company has a market capitalization of $30.22 billion, a PE ratio of 33.17, a P/E/G ratio of 0.77 and a beta of 0.94. Veeva Systems Inc. has a 52-week low of $148.05 and a 52-week high of $310.50.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. The firm had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.Veeva Systems’s revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.97 earnings per share. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. On average, research analysts anticipate that Veeva Systems Inc. will post 6.65 EPS for the current year.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.